Good MorningEquity markets continue to fall on Wednesday despite an early morning attempt to rebound. The S&P 500 fell more than 0.25% at the session low, a small decline but one that put it below the 30-day moving average. At this level, there is a risk that short-term traders will start selling the market and turn a small price pullback into a much larger one.
Among the causes for market softness was a weaker-than-expected JOLTs report. The JOLTs report tracks job openings and shows job availability decreasing, raising the risk of a labor-led recession. Job losses will compound in that scenario, causing a significant pullback in consumer spending and leading the S&P 500 into a tailspin as the earnings outlook is reassessed. The caution is that a single data point or month of data is not a trend and labor markets remain healthy on balance. Featured: Insider sneaky bets exposed (Ad) 
|
Finance | |
While investors today want to emulate what Warren Buffett and other mega investors in the stock market are trying to do, they often forget that they are in the tenth chapter of their journey, while most retail investors should be trying to figure out what these professionals did in their beginning... Read the Full Story |
|
From Our Partners | | BioStem Technologies (NASDAQ: BSEM) just completed its Nasdaq debut, and hospital revenue already makes up about 87% of first-quarter sales.
The BioTissue acquisition added the Neox and Clarix portfolios and GPO relationships, while the direct sales team grew from 18 to 35 reps in a single quarter.
A peer-reviewed trial found a 53% complete wound closure rate with BioREtain allografts versus 31% for standard care, backing coverage from Zacks Small-Cap Research and H.C. Wainwright. | | Discover how BSEM is building out its regenerative medicine platform |
|
Consumer Discretionary | |
Dick’s Sporting Goods (NYSE: DKS) can compete with the likes of Walmart (NYSE: WMT) and Target (NYSE: TGT) and continue to gain market share because of its quality. Not all of the sporting goods products in Walmart and Target are poor quality, but many are; sporting enthusiasts who know the ... Read the Full Story |
|
Technology | |
Two emotions rule financial markets: fear and greed. Fear can arise when a stock position is losing money, and greed rears its head when a stock position is making money. The fear of missing out (FOMO) on a potential winner can trigger both emotions. People tend to react when fear or greed builds ... Read the Full Story |
|
From Our Partners | | Washington is racing to get the CLARITY Act signed into law.... And Wall Street has been waiting for exactly this moment.
For years, the biggest banks, asset managers, and trading firms have kept most of their serious capital on the crypto sidelines… not because they don't believe in it, but because there was no legal framework they could operate within.
Our team has spent months identifying the one overlooked altcoin we believe is positioned to benefit more than anything else when that happens. | | Get our #1 crypto for the Clarity Act (time-sensitive opportunity) |
|
Utilities | |
When a bear market occurs, it’s not impossible to find places to preserve or even grow wealth in the stock market. Some companies naturally have aspects of their business that allow them to perform well when it feels like all the market wants to do is fall. We’ll look at three stocks t... Read the Full Story |
|
Healthcare | |
AbbVie (NYSE: ABBV) is a global biopharmaceutical company long synonymous with its blockbuster drug, Humira. While the drug's success has propelled AbbVie to great heights, its recent patent expiration has greatly influenced the company's future.
While the "Humira cliff" is undeniably significant... Read the Full Story |
|
From Our Partners | | Unitree's IPO grabbed headlines, but a handful of already-public robotics companies have been quietly delivering results that look nothing like hype.
One robotics-and-testing firm grew quarterly revenue from $686 million to $1.282 billion year over year and broke out above a $422.11 buy point. A warehouse robotics company exited the quarter with a $22.7 billion backlog and $2.0 billion in cash with no debt. A robotic surgery leader placed 431 systems in a single quarter. | | Get the free robotics stock report now. |
|
Healthcare | |
There are many reasons for the market to be bearish today, but the primary ones are the FOMC and the outlook for interest rates. The FOMC is set to cut rates this year, but the economic data isn’t cooperating the way the market would like. The labor data remains solid, showing resilience des... Read the Full Story |
|
Consumer Discretionary | |
Wingstop Inc. (NASDAQ: WING) has a simple restaurant concept. Sell chicken wings, chicken tenders and chicken sandwiches with fries and sodas. It offers a simple menu and sells a relatively simple product, chicken.
We're not talking locally sourced grass-fed steaks, hand-made sides, customized sa... Read the Full Story |
|
Technology | |
Despite a strong start to the year, shares of tech titan Salesforce Inc. (NYSE: CRM) have been having a lackluster end to the summer. They gained 150% through the start of March before falling more than 30% in June due to some dodgy earnings.
Since then, they’ve been working hard to recl... Read the Full Story |
|
Technology | |
While semiconductor developer Marvell Technology, Inc. (NASDAQ: MRVL) is a benefactor in the artificial technology (AI) revolution, headline numbers for their second-quarter fiscal 2025 results don’t paint the immediate upside potential. This is because the rest of the business shows weaknes... Read the Full Story |
|
Consumer Discretionary | |
After a sharp sell-off that pushed the SPDR Homebuilders ETF (NYSE: XHB) toward crucial support near $105 during the early August carry trade unwind panic, the sector has rebounded impressively. Now sitting just 3% away from its 52-week high, XHB is consolidating near a significant breakout zone o... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York. | | View Today's Stock Pick |
|
